Results of a Phase II Study with Bendamustine and Ofatumumab in Untreated Indolent B-Cell Non-Hodgkin's Lymphoma

被引：0
|
作者：
Fowler, Nathan H. [1 ]
Kahanic, Stephen P. [2 ]
Forero, Andres [3 ]
Munteanu, Mihaela C. [4 ]
Davis, Glen L. [4 ]
Brown, Peter [4 ]
Van Den Neste, Eric [5 ]
Offner, Fritz C. [6 ]
Bron, Dominique [7 ]
Czuczman, Myron S. [8 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Siouxland Hematol Oncol, Sioux City, IA USA
[3] Univ Alabama, Birmingham, AL USA
[4] Cephalon Inc, Frazer, PA USA
[5] Clin Univ UCL St Luc, Brussels, Belgium
[6] Univ Hosp Ghent, Ghent, Belgium
[7] Inst Jules Bordet, B-1000 Brussels, Belgium
[8] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：353 / 353
页数：1
相关论文
共 50 条
  • [1] Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin’s lymphoma
    Myron S. Czuczman
    Stephen Kahanic
    Andres Forero
    Glen Davis
    Mihaela Munteanu
    Eric Van Den Neste
    Fritz Offner
    Dominique Bron
    Donald Quick
    Nathan Fowler
    Annals of Hematology, 2015, 94 : 633 - 641
  • [2] Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin's lymphoma
    Czuczman, Myron S.
    Kahanic, Stephen
    Forero, Andres
    Davis, Glen
    Munteanu, Mihaela
    Van den Neste, Eric
    Offner, Fritz
    Bron, Dominique
    Quick, Donald
    Fowler, Nathan
    ANNALS OF HEMATOLOGY, 2015, 94 (04) : 633 - 641
  • [3] PHARMACOKINETICS AND TOLERABILITY OF OFATUMUMAB AND BENDAMUSTINE IN PATIENTS WITH INDOLENT B-CELL NON-HODGKIN'S LYMPHOMA
    Forero-Torres, A.
    Chandler, J. C.
    Iyer, S. P.
    Kanate, A. S.
    Quinlan, M.
    Hoever, P.
    Izquierdo, M.
    Duval, V.
    Madan, S.
    HAEMATOLOGICA, 2017, 102 : 469 - 469
  • [4] Phase 1 Study Evaluating Pharmacokinetics and Tolerability of Ofatumumab Combined With Bendamustine in Patients With Indolent B-Cell Non-Hodgkin's Lymphoma
    Forero-Torres, Andres
    Chandler, Jason Claud
    Iyer, Swaminathan P.
    Kanate, Abraham S.
    Quinlan, Michelle
    Hoever, Petra
    Izquierdo, Miguel
    Davis, Jaclyn
    Madan, Sumit
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (09): : 1099 - 1109
  • [5] Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
    Ohmachi, Ken
    Ando, Kiyoshi
    Ogura, Michinori
    Uchida, Toshiki
    Itoh, Kuniaki
    Kubota, Nobuko
    Ishizawa, Kenichi
    Yamamoto, Joji
    Watanabe, Takashi
    Uike, Naokuni
    Choi, Ilseung
    Terui, Yasuhito
    Usuki, Kensuke
    Nagai, Hirokazu
    Uoshima, Nobuhiko
    Tobinai, Kensei
    CANCER SCIENCE, 2010, 101 (09) : 2059 - 2064
  • [6] Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma
    Robinson, K. Sue
    Williams, Michael E.
    van der Jagt, Richard H.
    Cohen, Philip
    Herst, Jordan A.
    Tulpule, Anil
    Schwartzberg, Lee S.
    Lemieux, Bernard
    Cheson, Bruce D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (27) : 4473 - 4479
  • [7] Ixazomib in Previously Untreated Indolent B-Cell Non-Hodgkin Lymphoma
    Graf, Solomon A.
    Lynch, Ryan C.
    Coffey, David G.
    Shadman, Mazyar
    Kanan, Sandra
    Libby, Edward N., III
    Warren, Edus H.
    Godwin, Colin
    Gooley, Ted
    Fromm, Jonathan R.
    Gopal, Ajay K.
    BLOOD, 2018, 132
  • [8] Phase II results of bendamustine in combination with rituximab in relapsed indolent non-Hodgkin's lymphoma
    van der Jagt, Richard H.
    Cohen, Philip
    Cheson, Bruce D.
    Tulpule, Anil
    Herst, Jordan A.
    Lemieux, Bernard
    Schwartzberg, Lee S.
    Robinson, K. Sue
    Oliver, Jennifer W.
    Williams, Michael E.
    ANNALS OF ONCOLOGY, 2006, 17 : 200 - 200
  • [9] Phase II trial of bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or elderly mantle cell lymphoma in Japan.
    Ishizawa, Kenichi
    Ogura, Michinori
    Maruyama, Dai
    Abe, Yasunobu
    Ando, Kiyoshi
    Izutsu, Koji
    Terui, Yasuhito
    Yoshitaka, Imaizumi
    Fukuhara, Noriko
    Uchida, Toshiki
    Choi, Ilseung
    Ohmachi, Ken
    Yamamoto, Go
    Tobinai, Kensei
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan
    Ogura, Michinori
    Ishizawa, Kenichi
    Maruyama, Dai
    Uike, Naokuni
    Ando, Kiyoshi
    Izutsu, Koji
    Terui, Yasuhito
    Imaizumi, Yoshitaka
    Tsukasaki, Kunihiro
    Suzuki, Kenshi
    Izumi, Tohru
    Usuki, Kensuke
    Kinoshita, Tomohiro
    Taniwaki, Masafumi
    Uoshima, Nobuhiko
    Suzumiya, Junji
    Kurosawa, Mitsutoshi
    Nagai, Hirokazu
    Uchida, Toshiki
    Fukuhara, Noriko
    Choi, Ilseung
    Ohmachi, Ken
    Yamamoto, Go
    Tobinai, Kensei
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 105 (04) : 470 - 477
12345